Enhancing Cardiac Myosin Function with an Abiotic Energy Source
نویسندگان
چکیده
Cardiac myosin is the force generating molecular motor of heart making it a potential target to improve cardiac function in failure patients. We sought enhance and motion capacity porcine vitro by replacing ATP with azobenzene triphosphate (AzoTP), an abiotic synthetic energy source. In motility assay translocated actin filaments 50% faster using this compound compared (1.7 ± 0.09 vs. 1.2 µm ∙ s-1, p<0.05). also measured effect on myosin's force-generating mini-ensemble (∼10 heads) three-bead laser trap assay. Preliminary findings suggest that when ortho-AzoTP substrate generates more than twice as does (0.69 0.01 0.30 pN respectively). To begin delineate mechanism increased velocity we filament concentration found at half-maximal activation was dramatically reduced suggesting has affinity for (400 1223uM). The saturating may be result accelerated rate ortho-AzoDP-release from active site. Additionally, frequency binding events much greater (5 2Hz), increase due attachment filament. Thus, these demonstrate alternative can myosin. A deeper investigation mechanisms underlying enhancement reveal novel approaches pathological conditions such failure.
منابع مشابه
Cardiac myosin-binding protein-C phosphorylation and cardiac function.
The role of cardiac myosin binding protein-C (cMyBP-C) phosphorylation in cardiac physiology or pathophysiology is unclear. To investigate the status of cMyBP-C phosphorylation in vivo, we determined its phosphorylation state in stressed and unstressed mouse hearts. cMyBP-C phosphorylation is significantly decreased during the development of heart failure or pathologic hypertrophy. We then gene...
متن کاملAn a-cardiac myosin heavy chain gene mutation impairs contraction and relaxation function of cardiac myocytes
SONG-JUNG KIM,1 KENJI IIZUKA,1 RALPH A. KELLY,2 YONG-JIAN GENG,1 SANFORD P. BISHOP,1 GUIPING YANG,1 AMELIA KUDEJ,1 BRADLEY K. MCCONNELL,3 CHRISTINE E. SEIDMAN,4 JONATHAN G. SEIDMAN,3 AND STEPHEN F. VATNER1 1Cardiovascular and Pulmonary Research Institute, Allegheny University of the Health Sciences, Pittsburgh, Pennsylvania 15212; 3Department of Genetics, Harvard Medical School and Howard Hughe...
متن کاملAn α-cardiac myosin heavy chain gene mutation impairs contraction and relaxation function of cardiac myocytes.
Left Ventricular (LV) myocytes were isolated from 15-wk-old male mice bearing the Arg403 → Gln α-cardiac myosin heavy chain missense mutation (α-MHC403/+), a model of familial hypertrophic cardiomyopathy. LV myocytes were classified morphologically: type I, rod shaped with parallel myofibrils; type II, irregularly shaped, shorter and wider than wild-type (WT) control cells, with parallel myofib...
متن کاملImprovement of cardiac function by a cardiac Myosin activator in conscious dogs with systolic heart failure.
BACKGROUND Therapy for chronic systolic heart failure (sHF) has improved over the past 2 decades, but the armamentarium of drugs is limited and consequently sHF remains a leading cause of death and disability. In this investigation, we examined the effects of a novel cardiac myosin activator, omecamtiv mecarbil (formerly CK-1827452) in 2 different models of heart failure. METHODS AND RESULTS ...
متن کاملA critical function for Ser-282 in cardiac Myosin binding protein-C phosphorylation and cardiac function.
RATIONALE Cardiac myosin-binding protein-C (cMyBP-C) phosphorylation at Ser-273, Ser-282, and Ser-302 regulates myocardial contractility. In vitro and in vivo experiments suggest the nonequivalence of these sites and the potential importance of Ser-282 phosphorylation in modulating the protein's overall phosphorylation and myocardial function. OBJECTIVE To determine whether complete cMyBP-C p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Biophysical Journal
سال: 2021
ISSN: ['0006-3495', '1542-0086']
DOI: https://doi.org/10.1016/j.bpj.2020.11.1622